Homeobox A13 (HOXA13) gene which is upregulated almost 500-fold is reported to be an unfavorable prognostic factor and novel oncogene for prostate cancer 55 and is also suggested to be used as biomarker for prognosis in bladder cancer 56. This evidence concerns the gene HOXA13 and urinary bladder carcinoma.